Pediatric Pulmonary Medicine
The Division of Pediatric Pulmonary Medicine at MassGeneral Hospital for Children is a well-established clinical, training and research program. The group provides multidisciplinary comprehensive consultation, diagnostic and management services for a wide array of pulmonary conditions.
Meet the Team
- T. Bernard Kinane, MD
- Joshua A. Boyce, MD
- Anna L. Cook, MD
- M. Shannon Fracchia, MD
- Allen Lapey, MD
- Samuel Mark Moskowitz, MD
- Benjamin A. Nelson, MD
- Natan Noviski, MD
- Christina Vestergaard Scirica, MD, MPH
- Daniel C. Shannon, MD
- Sze Man Tse, MDCM
- Lael Yonker, MD
- Joan W. Murphy, RN, MBA, AE-C
- Anita St. John, RN, AE-C
- Elisabeth Scannell Stieb, RN, BSN, AE-C
The Division of Pediatric Pulmonary Medicine at MassGeneral Hospital for Children has provided comprehensive care for children with respiratory disorders for more than 40 years. The group provides multidisciplinary consultation, diagnostic and management services for a wide array of pulmonary conditions including:
- Bronchopulmonary dysplasia
- Cystic fibrosis
- Recurrent and persistent pneumonias
- Unusual respiratory infections
- Aerodigestive disorders
- Immune deficiencies
- Congenital lung malformations
- Neuromuscular disorders leading to chronic lung problems
- Interstitial lung disease
- Exercise-related disorders
- Sleep-related breathing problems
We constantly strive to deliver the best family-centered, cutting-edge pediatric pulmonary care in close association with local primary care providers.
The Pediatric Pulmonary division currently has nine faculty members and three fellows. Many of our faculty members are recognized as leaders in their field and have received both local and national awards. Building on our solid clinical platform, we provide training for fellows, residents, Harvard Medical School students and healthcare professionals.
Special services in the Division of Pediatric Pulmonary include the Pediatric Pulmonary Function Laboratory, cardiopulmonary exercise testing, Sleep Laboratory, sweat testing and fiberoptic bronchoscopy.
A major strength of the Pulmonary Division is our research to improve our understanding of asthma, cystic fibrosis, lung inflammation and regeneration. We have a number of active research programs to look at the mechanisms that induce and control inflammation in the lung, signaling pathways that can be induced to activated regeneration, the networks that control breathing and clinical studies to help develop new therapies for cystic fibrosis.
Pediatric Pulmonary Locations Near You
Our pulmonologists practice at MassGeneral Hospital for Children in Boston and also at community locations including Newton-Wellesley Hospital, Massachusetts Eye and Ear Infirmary and MassGeneral for Children at North Shore Medical Center in Salem, MA.
A Tradition of Caring
At MassGeneral Hospital for Children, we know that the time of your child's diagnosis and treatment is a very stressful one and we strive to provide an open, welcoming environment.
Bronchitis is an inflammation of the breathing tubes (airways) that are called bronchi, which causes increased production of mucus and other changes.
Asthma is a chronic, inflammatory disease in which the airways become sensitive to allergens (any substance that triggers an allergic reaction).
Approximately 6.5 million children have been diagnosed with asthma according to the Centers for Disease Control and Prevention (CDC). Asthma is one of the most common, serious, chronic diseases among children, accounting for 14 million absences from school each year.
Chronic bronchitis is a long-term inflammation of the bronchi, which results in increased production of mucus, as well as other changes.
COPD is a term that refers to a group of lung diseases that can interfere with normal breathing.
Chronic pain is long-standing pain that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis.
Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system. CF causes the body to produce thick, sticky mucus that leads to progressive lung infection and difficulty gaining weight.
Goodpasture syndrome is a rare, autoimmune disease that can affect the lungs and kidneys.
Interstitial lung diseases are named after the tissue between the air sacs of the lungs called the interstitium - the tissue affected by fibrosis (scarring).
Lung cancer is cancer that usually starts in the lining of the bronchi (the main airways of the lungs), but can also begin in other areas of the respiratory system, including the trachea, bronchioles, or alveoli.
Occupational asthma is a type of asthma caused by exposure to inhaled irritants in the workplace. Symptoms may disappear when the irritants that caused the asthma are avoided.
Repeated and long-term exposure to certain irritants on the job can lead to an array of lung diseases that may have lasting effects, even after exposure ceases.
Pneumonia is an inflammation of the lungs caused by bacteria, viruses, or chemical irritants.
Pulmonary hypertension is a lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels.
Emphysema is a chronic lung condition in which alveoli, or air sacs, may be destroyed, narrowed, collapsed, stretched or over-inflated.
Sarcoidosis is a rare disease that results from inflammation.
Restless legs syndrome (RLS) is a sleep disorder in which a person experiences unpleasant sensations in the legs.
Sleep apnea is a serious breathing disorder that causes brief interruptions of breathing during sleep.
Snoring is the sound that occurs during sleep when flow of air is obstructed in the area where the tongue and upper throat meet the soft palate and uvula.
The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.
Cystic Fibrosis: VX09-809-102: A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Lumacaftor Monotherapy, and Lumacaftor and Ivacaftor Combination Therapy in Subjects with Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation [Cohort 4]
Researchers in the Center for Regenerative Medicine at Massachusetts General Hospital and the Harvard Stem Cell Institute have taken a critical step toward a treatment for Cystic fibrosis and other fatal lung diseases.
MassGeneral Hospital for Children(MGHFC) recently rolled out two new clinics – the Angelman Syndrome Clinic and the Child and Adolescent Medical Psychiatry (ChAMP) Clinic – and a new weight and asthma program, Inspired Health.
Pediatric Pulmonary MedicineMGH Professional Office Building
275 Cambridge Street, Suite 530
Boston, MA 02114
Public Transportation Access: yes
Disabled Access: yes
To schedule an appointment with a MassGeneral for Children pediatric specialist, please call 888-644-3248 or complete our online appointment form to request an appointment.
Physicians may call 888-644-3211 or use the online referral form and the Access & New Appointment Center will call your patient within 1 business day.
Contact MassGeneral Hospital for Children to schedule an appointment with one of our specialists.
Secure, convenient online access to your child's health information whenever you need it.